South Korean Pharmaceuticals & Biotech Big Green Snowflakes

Caregen

Market Cap: ₩2.9t

A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.

iNtRON Biotechnology

Market Cap: ₩119.3b

Engages in the development of novel drugs in South Korea.

MFC

Market Cap: ₩35.1b

Operates as a pharmaceutical company in South Korea.

MOA Life Plus

Market Cap: ₩60.6b

Engages in the medicine and consumer business in South Korea.

IMB Dx

Market Cap: ₩138.8b

Provides liquid biopsy platform in South Korea.

SLS BIO

Market Cap: ₩26.9b

Develops diagnostic technologies in South Korea.

ABL Bio

Market Cap: ₩5.0t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

NIBEC

Market Cap: ₩353.4b

A healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

Green Lifescience

Market Cap: ₩50.4b

Engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally.

Qurient

Market Cap: ₩601.8b

A biotech company, engages in the research and development of drugs to address unmet medical needs in Korea and internationally.

CHA Vaccine Research Institute

Market Cap: ₩73.3b

Cha Vaccine Research Institute Co., Ltd., a research-oriented biotechnology company, researches and develops a range of vaccine products targeting infectious and chronic diseases.

BioInfra

Market Cap: ₩25.1b

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials.

KoBioLabs

Market Cap: ₩109.3b

Provides microbiome therapeutics for metabolic, immune, and neurological diseases.

CellBion

Market Cap: ₩229.5b

Engages in the research and development of radiopharmaceutical products.

Cytogen

Market Cap: ₩53.5b

A biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea.

Oncocross

Market Cap: ₩110.4b

Develops drugs for the treatment of cancers, rare diseases, and intractable diseases in South Korea.

Celemics

Market Cap: ₩24.9b

Designs, manufactures, and distributes sequencing kits in South Korea.

Hyundai ADM Bio

Market Cap: ₩118.4b

A contract research organization, provides clinical services in Asia.

ImmuneOncia Therapeutics

Market Cap: ₩402.8b

An immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer.

Naturalendo Tech

Market Cap: ₩83.7b

Engages in the research, development, manufacture, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea.

WooGene B&G

Market Cap: ₩27.0b

Engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.

PeopleBio

Market Cap: ₩33.9b

A biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases.

EyeGene

Market Cap: ₩65.1b

Engages in the research and development of biopharmaceutical drugs for the treatment and prevention of age-related diseases in South Korea.

Optipharm.CO.LTD

Market Cap: ₩74.5b

Operates as a biomedical solution provider in South Korea.

Genome

Market Cap: ₩80.8b

A clinical stage biotechnology company, researches and develops novel-targeted immuno-oncology therapeutics in the field of immuno-oncology, skin diseases, and autism in South Korea.

Y-Biologics

Market Cap: ₩199.4b

An antibody new drug development platform company, engages in the research and development of immuno-oncology drugs and antibody drugs.

D&D Pharmatech

Market Cap: ₩2.2t

A clinical-stage biotech company, develops medicines in South Korea and the United States.

Psomagen

Market Cap: ₩71.6b

Engages in the provision omics solutions and contract laboratory services.

Celestra

Market Cap: ₩13.5b

A biotechnology company, provides genome-based cancer and disease diagnostic solutions.

Union Korea Pharm

Market Cap: ₩15.4b

Engages in the research, development, production, and sale of prescription drugs in South Korea.

curacleltd

Market Cap: ₩86.6b

Curacle Co., Ltd., a bio-venture business, engages in the research and development of drugs for diseases caused by aging process and damage to blood vessels.

Genomictree

Market Cap: ₩529.6b

A biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases.

GL Pharm Tech

Market Cap: ₩83.2b

Provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea.

Shinpoong PharmaceuticalLtd

Market Cap: ₩696.5b

Manufactures and sells pharmaceutical products in South Korea.

Pharos iBio

Market Cap: ₩71.5b

Develops treatments for rare and refractory diseases using AI based drug development platform in South Korea.

SillaJen

Market Cap: ₩428.2b

Develops and commercializes oncolytic immunotherapy products in South Korea.